It was reported that a pericardial effusion occurred.During a watchman left atrial appendage closure (laac) procedure to treat atrial fibrillation (a fib) and bleed risk, a versacross connect kit was selected for use.The transseptal puncture (tsp) was performed and watchman closure device was deployed, met all release criteria, and the device was released.During the end of the procedure, a pericardial effusion was noted resulting in hemodynamic compromise and a pericardial tap was performed.The patient was transferred to computed tomography (ct) surgery where no additional discoveries were found.The patient remained in the hospital for treatment/recovery.The device is not expected to be returned for analysis.It was further reported that there were no issues noted during tsp workflow or with the versacross products (dilator or rf wire).In the physician's opinion, the versacross devices did not contribute to the patient complication.
|